Semaphorin 3C as a Therapeutic Target in Prostate and Other Cancers

por Hui, Daniel H.F., Tam, Kevin J., Jiao, Ivy Z.F., Ong, Christopher J.
Publicado 2019

Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics

por Saeednejad Zanjani, Leili, Madjd, Zahra, Rasti, Arezoo, Asgari, Mojgan, Abolhasani, Maryam, Tam, Kevin J., Roudi, Raheleh, Mælandsmo, Gunhild Mari, Fodstad, Øystein, Andersson, Yvonne
Publicado 2019

A TRIP230-Retinoblastoma Protein Complex Regulates Hypoxia-Inducible Factor-1α-Mediated Transcription and Cancer Cell Invasion

por Labrecque, Mark P., Takhar, Mandeep K., Jagdeo, Julienne M., Tam, Kevin J., Chiu, Christina, Wang, Te-Yu, Prefontaine, Gratien G., Cox, Michael E., Beischlag, Timothy V.
Publicado 2014

Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner

por Tam, Kevin J., Dalal, Kush, Hsing, Michael, Cheng, Chi Wing, Khosravi, Shahram, Yenki, Parvin, Tse, Charan, Peacock, James W., Sharma, Aishwariya, Chiang, Yan Ting, Wang, Yuzhuo, Cherkasov, Artem, Rennie, Paul S., Gleave, Martin E., Ong, Christopher J.
Publicado 2016

The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells

por Labrecque, Mark P., Takhar, Mandeep K., Nason, Rebecca, Santacruz, Stephanie, Tam, Kevin J., Massah, Shabnam, Haegert, Anne, Bell, Robert H., Altamirano-Dimas, Manuel, Collins, Colin C., Lee, Frank J.S., Prefontaine, Gratien G., Cox, Michael E., Beischlag, Timothy V.
Publicado 2016

Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cells

por Tam, Kevin J., Hui, Daniel H. F., Lee, Wilson W., Dong, Mingshu, Tombe, Tabitha, Jiao, Ivy Z. F., Khosravi, Shahram, Takeuchi, Ario, Peacock, James W., Ivanova, Larissa, Moskalev, Igor, Gleave, Martin E., Buttyan, Ralph, Cox, Michael E., Ong, Christopher J.
Publicado 2017

Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells

por Yenki, Parvin, Bhasin, Satyam, Liu, Liang, Nabavi, Noushin, Cheng, Chi Wing, Tam, Kevin J, Peacock, James W, Adomat, Hans H, Tombe, Tabitha, Fazli, Ladan, Ivanova, Larissa, Dusek, Christopher, Khosravi, Shahram, Guns, Emma S Tomlinson, Wang, Yuzhuo, Buttyan, Ralph, Gleave, Martin E, Ong, Christopher J
Publicado 2023

Targeting Semaphorin 3C in Prostate Cancer With Small Molecules

por Lee, Chung C W, Munuganti, Ravi Shashi Nayana, Peacock, James W, Dalal, Kush, Jiao, Ivy Z F, Shepherd, Ashley, Liu, Liangliang, Tam, Kevin J, Sedgwick, Colin G, Bhasin, Satyam, Lee, Kevin C K, Gooding, Luke, Vanderkruk, Benjamin, Tombe, Tabitha, Gong, Yifan, Gleave, Martin E, Cherkasov, Artem, Ong, Christopher J
Publicado 2018

SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1

por Peacock, James W, Takeuchi, Ario, Hayashi, Norihiro, Liu, Liangliang, Tam, Kevin J, Al Nakouzi, Nader, Khazamipour, Nastaran, Tombe, Tabitha, Dejima, Takashi, Lee, Kevin CK, Shiota, Masaki, Thaper, Daksh, Lee, Wilson CW, Hui, Daniel HF, Kuruma, Hidetoshi, Ivanova, Larissa, Yenki, Parvin, Jiao, Ivy ZF, Khosravi, Shahram, Mui, Alice L‐F, Fazli, Ladan, Zoubeidi, Amina, Daugaard, Mads, Gleave, Martin E, Ong, Christopher J
Publicado 2018